A 13-week Multinational, Randomized, Double-Blind, Placebo-Controlled, Dose-Response Trial Assessing the Safety, Tolerability and Efficacy of AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus
收藏官方服务：
资源简介：
To evaluate the dose-response relationship of AVE0010 administered once daily and twice daily with chronic dosing in metformin-treated subjects with type 2 diabetes
本数据集旨在评估接受二甲双胍治疗的2型糖尿病受试者中，AVE0010以每日一次及每日两次方案长期给药的量效关系
提供机构：
Vivli创建时间：
2022-02-02
